Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma

被引：0
|
作者：
Hanwool Jeon
Joonho Byun
Hayeong Kang
Kyunggon Kim
Eunyeup Lee
Jeong Hoon Kim
Chang Ki Hong
Sang Woo Song
Young-Hoon Kim
Sangjoon Chong
Jae Hyun Kim
Soo Jeong Nam
Ji Eun Park
Seungjoo Lee
机构：
[1] Asan Medical Center,Translational Biomedical Research Group, Asan Institute for Life Sciences
[2] University of Ulsan College of Medicine 88,Department of Neurological Surgery, Brain Tumor Center, Asan Medical Center
[3] Asan Medical Center,Asan Institute for Life Sciences
[4] University of Ulsan College of Medicine,Department of Pathology, Asan Medical Center
[5] University of Ulsan College of Medicine,Department of Radiology and Research Institute of Radiology, Asan Medical Center
[6] University of Ulsan College of Medicine,Bio
来源：
Journal of Translational Medicine | / 21卷
关键词：
Anti-angiogenic resistance; Prediction biomarker; Proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
    Jeon, Hanwool
    Byun, Joonho
    Kang, Hayeong
    Kim, Kyunggon
    Lee, Eunyeup
    Kim, Jeong Hoon
    Hong, Chang Ki
    Song, Sang Woo
    Kim, Young-Hoon
    Chong, Sangjoon
    Kim, Jae Hyun
    Nam, Soo Jeong
    Park, Ji Eun
    Lee, Seungjoo
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [2] Anti-angiogenic strategies in glioblastoma
    Guillamo, J. -S.
    [J]. REVUE NEUROLOGIQUE, 2011, 167 (10) : 662 - 667
  • [3] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Yasushi Soda
    Chad Myskiw
    Amy Rommel
    Inder M. Verma
    [J]. Journal of Molecular Medicine, 2013, 91 : 439 - 448
  • [4] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Soda, Yasushi
    Myskiw, Chad
    Rommel, Amy
    Verma, Inder M.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (04): : 439 - 448
  • [5] Anti-angiogenic therapies in the management of glioblastoma
    Schulte, Jessica D.
    Aghi, Manish K.
    Taylor, Jennie W.
    [J]. CHINESE CLINICAL ONCOLOGY, 2021, 10 (04)
  • [6] Gene expression changes underlying glioblastoma resistance to anti-angiogenic therapy
    Chen, William C.
    Jahangiri, Arman
    Yagnik, Garima
    Sidorov, Maxim
    Rick, Jonathan
    Kuang, Ruby
    DeLay, Michael
    Aghi, Manish K.
    [J]. CANCER RESEARCH, 2016, 76
  • [7] METABOLIC ANALYSIS OF GLIOBLASTOMA XENOGRAFTS AFTER ANTI-ANGIOGENIC TREATMENT
    Fack, F.
    Zheng, L.
    Frezza, C.
    Keunen, O.
    Kalna, G.
    Nazarov, P.
    Gottlieb, E.
    Niclou, S. P.
    Bjerkvig, R.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 58 - 58
  • [8] MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma
    Talati, Pratik
    El-Abtah, Mohamed
    Kim, Daniel
    Dietrich, Jorg
    Fu, Melanie
    Wenke, Michael
    He, Julian
    Natheir, Sharif N.
    Vangel, Mark
    Rapalino, Otto
    Vaynrub, Anna
    Arrillaga-Romany, Isabel
    Forst, Deborah A.
    Yen, Yi-Fen
    Andronesi, Ovidiu
    Kalpathy-Cramer, Jayashree
    Rosen, Bruce
    Batchelor, Tracy T.
    Gonzalez, R. Gilberto
    Gerstner, Elizabeth R.
    Ratai, Eva-Maria
    [J]. NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [9] Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors
    Dey, Nandini
    De, Pradip
    Brian, Leyland-Jones
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (10): : 1675 - 1698
  • [10] Current Role of Anti-Angiogenic Strategies for Glioblastoma
    Thomas, Alissa A.
    Omuro, Antonio
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 551 - 566
12345